Nonalcoholic fatty liver disease (NAFLD) is a global health issue, affecting nearly a 32 percent of adults 40 percent of men and 26 percent of women, according to the National Institutes of Health (NIH)
Remogliflozin (Remo), an inhibitor of the sodiumglucose cotransporter 2 (SGLT2) protein, is one of the most recently developed antidiabetic drugs for treating type 2 diabetes mellitus (T2DM)
For this reason, our capsules are produced in a fully compliant HACCP factory in Austria, in accordance with all manufacturing guidelines and under the strictest quality control
Unlike oral supplements, IV drips also help rehydrate your body and deliver electrolytes directly into your bloodstream, making you feel reinvigorated and ready to perform at your best
A lower GSH:GSSG ratio may indicate increased oxidative burden, environmental stress exposure, metabolic strain, or impaired recovery capacity